Recall Register

Device recall: Siemens epoc BGEM Test Card-In vitro diagnostic device for the quantitative testing of samples of heparinized or…

Class II FDA enforcement event 86378. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Sporadically inconsistent discrepant (low bias) glucose results on card lot 01-20095-10. Potential exists for a delay in diagnosis of hyperglycemia or unnecessary treatment for hypoglycemia.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Siemens Healthcare Diagnostics Inc started this device recall on 28 Aug 2020. The firm address in the FDA record is in Norwood, MA. FDA put the recall in Class II. FDA event 86378 has 1 product record. The first FDA enforcement report date is 23 Sep 2020. The record gives the status Terminated, with the termination date 9 Sep 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide Foreign: Canada

Recalling firm

Siemens Healthcare Diagnostics Inc, Norwood, MA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 86378: product records
Recall numberProductQuantityClassStatusReport date
Z-2970-2020Siemens epoc BGEM Test Card-In vitro diagnostic device for the quantitative testing of samples of heparinized or un-anticoagulated arterial, venous or capillary whole blood in the laboratory or at the point of care SMN#/Model #: 10736382463 boxes (50 test cards/box )Class IITerminated23 Sep 2020

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2020
916
Share of these events in Class II
93%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
333

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 86378. https://recallregister.com/fda/ii/86378/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide Foreign: Canada
What quantity of product is in FDA event 86378?
The FDA record gives this quantity: 463 boxes (50 test cards/box )
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2020 have the same class?
93% of the 916 device events that started in 2020 are in Class II.